Get the full Fathom Therapeutics company profile
Access contacts, investors, buying signals & more
Fathom Therapeutics has raised $47.0M in Series A funding. The company pairs quantum chemistry with AI to design novel drug molecules, predicting how they'll behave inside living cells.
That's the pitch behind its Microcosmos drug discovery engine, which Fathom says it's built to model molecular behavior in the cellular environment where drugs actually have to work. The company did not disclose its investors.
The AIxBio Series A rounds of 2026 (so far)* 🧬 1/ Warp Sciences 🇺🇸 · $215M · AI + robotic chemistry labs 2/ Collate 🇺🇸 · $95M · AI for drug development paperwork 3/ Infinimmune 🇺🇸 · $75M · human antibodies + antibody language models 4/ Biorce 🇪🇸 · $52.
5M · AI for clinical trial design 5/ Xellar Biosystems 🇺🇸 · $50M (A + A+) · organ-on-chip + AI virtual cell 6/ Fathom Therapeutics 🇺🇸 · $47M · physics + AI small-molecule design 7/ Adaptyv 🇨🇭 · $40M · automated wet lab for AI protein design 8/ Biolevate 🇫🇷 · €30M · AI agents for regulated pharma workflows 9/ Beyang Therapeutics 🇨🇳 · $30M · AI-driven small-molecule design 10/ Converge Bio
offe market
We love a good deal Everything on our site is off-price, up to 80% off everything, all the time. How it works We buy excess inventory from thoughtful, high quality brands at a discount and then pass those savings on to our customers. Brands we carry We focus on Millennial and Gen Z favorites like Baggu, Lisa Says Gah, and others you won't find at traditional off-price retailers. The offe market difference Millions of pounds of clothing go to waste each year so we work with our brands to ensure more clothing is worn, not wasted.
$3.0M Seed
today
Nyquis
Nyquis builds real-time grid intelligence for a safer, more reliable, and more capable electric system. Clear insights from complex grid data help engineers, operators, planners, and field crews act sooner and plan with confidence. Utilities can detect emerging faults, prevent outages and wildfires, uncover available capacity, and connect new loads faster. See the grid. Protect the future.
$6.3M Seed
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Claimlane Denmark | Series a | $6.3M | today |
| 2 |  Uncover Brazil | Series a | $16.0M | today |
today
| $7.2B |
| 2y ago |
| 3 |  GRAIL United States | Unknown | $7.1B | 2y ago |
| 4 |  Illumina United States | Unknown | $7.1B | 2y ago |
| 5 |  RemeGen Biosciences United States | Grant | $5.6B | 9mo ago |
| 3 |
 LARQ United States |
| Series a |
| $10.0M |
| today |
| 4 |  URobotics Corp. | Series a | $29.8M | today |
| 5 |  CheomdanLab.Inc | Series a | $3.4M | today |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
See who invested in Fathom Therapeutics and reach their contacts directly.
Start free trialNyquis
Recently received
Proofbacked
Recently received
Yurideks
Recently received
